Novartis India Outperforms Sector Amid Strong Upward Trend and Resilience
Novartis India has experienced notable stock performance, gaining significantly on May 26, 2025, and outperforming its sector. The stock has shown a strong upward trend over the past week and is trading above all key moving averages, highlighting its robust performance in both short- and long-term contexts.
Novartis India has shown significant activity today, gaining 8.31% on May 26, 2025. This performance has allowed the stock to outperform its sector by 6.82%. Over the past week, Novartis India has demonstrated a strong upward trend, with a cumulative return of 21.81% over seven consecutive days. The stock reached an intraday high of Rs 1,046.9, reflecting a 7.58% increase during the trading session.In terms of moving averages, Novartis India is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust short- to long-term performance.
While the broader market, represented by the Sensex, has also seen gains, climbing 0.56% today, Novartis India’s performance stands out. The Sensex is currently 4.62% away from its 52-week high, with mega-cap stocks leading the market's upward momentum.
Despite a challenging year-to-date performance of 14.59% compared to the Sensex's 5.16%, Novartis India has shown resilience, particularly over longer time frames, with a notable 82.23% increase over the past three years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
